News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

U.S. Court Denies Sequenom Inc. (SQNM)'s Preliminary Injunction Against Ariosa Diagnostics, Inc.


7/9/2012 8:20:24 AM

Sequenom Inc., a life sciences company providing innovative genetic analysis solutions, has confirmed that the United States District Court for the Northern District of California has denied a motion by Sequenom for a preliminary injunction against Ariosa Diagnostics. “While obviously a disappointing preliminary outcome in our efforts to enforce an issued US patent against infringement, yesterday's decision is by no means a final ruling on the infringement or the validity of the '540 patent, but is one step in a long process to enforce our patent and protect our proprietary rights in the non-invasive prenatal testing marketplace,” said Harry F Hixson, Jr., PhD, chairman and CEO, Sequenom, Inc.

Read at PharmaBiz


comments powered by Disqus
PharmaBiz
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES